{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T01:25:26Z","timestamp":1795224326138,"version":"4.10.3"},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"7","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The first biomarker-based cervical cancer screening test, p16\/Ki-67 dual-stained cytology (DS), has been clinically validated and approved in the United States for triage of women being screened for cervical cancer who test positive for high-risk human papillomavirus (hrHPV). The primary aim of this work is to evaluate the cost-effectiveness of DS triage after co-testing findings of positive non-16\/18 HPV types and atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions cytology. A payer-perspective Markov microsimulation model was developed to assess the impact of DS reflex testing. Each comparison simulated 12,250 screening-eligible women through health states defined by hrHPV status and genotype, cervical intraepithelial neoplasia grades 1\u20133, invasive cervical cancer (ICC) by stage, and cancer-related or non-cancer death. Screening test performance data were from the IMPACT clinical validation trial. Transition probabilities were from population and natural history studies. Costs of baseline medical care, screening visits, tests, procedures, and ICC were included. DS reflex after co-testing was cost-effective with incremental cost-effectiveness ratios per quality-adjusted life-year gained of $15,231 [95% confidence interval (CI), $10,717\u2013$25,400] compared with co-testing with hrHPV pooled primary and genotyped reflex testing, and $23,487 (95% CI, $15,745\u2013$46,175) compared with co-testing with hrHPV genotyping with no reflex test. Screening and medical costs and life-years increased, while ICC costs and risk of ICC death decreased. Incorporating DS reflex into co-testing cervical cancer screening algorithms is projected to be cost-effective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Prevention Relevance:<\/jats:title>\n                    <jats:p>The p16\/Ki-67 dual-stained cytology (DS) test was recently approved in the United States as a reflex test for cervical cancer screening following positive high-risk human papillomavirus (hrHPV) test results. Adding DS reflex to hrHPV and cervical cytology co-testing strategies in the United States is expected to be cost-effective per life-year or quality-adjusted life-year gained.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/1940-6207.capr-22-0455","type":"journal-article","created":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T16:47:00Z","timestamp":1684687620000},"page":"393-404","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cost-effectiveness of p16\/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening"],"prefix":"10.1158","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7648-883X","authenticated-orcid":false,"given":"Diane M.","family":"Harper","sequence":"first","affiliation":[{"name":"1Department of Family Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Department of Obstetrics & Gynecology, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"3Department of Women's and Gender Studies, University of Michigan College of Literature, Science, and the Arts, Ann Arbor, Michigan."},{"name":"4Department of Bioengineering, School of Engineering, University of Michigan, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0513-5723","authenticated-orcid":false,"given":"Rye J.","family":"Anderson","sequence":"additional","affiliation":[{"name":"5Guidehouse Inc. New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6665-2807","authenticated-orcid":false,"given":"Ed","family":"Baker","sequence":"additional","affiliation":[{"name":"6Roche Molecular Systems Inc., Pleasanton, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3327-7789","authenticated-orcid":false,"given":"Tiffany M.","family":"Yu","sequence":"additional","affiliation":[{"name":"7Guidehouse Inc. San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"2025112418274881400_bib1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2017.19872","article-title":"Screening for cervical cancer in primary care: a decision analysis for the US preventive services task force","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"key":"2025112418274881400_bib2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement","volume":"320","author":"U.S. Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"key":"2025112418274881400_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ygyno.2021.06.029","article-title":"Uptake of co-testing with HPV and cytology for cervical screening: a population-based evaluation in the United States","volume":"162","author":"Cuzick","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2025112418274881400_bib4","first-page":"43","article-title":"Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap\/HPV co-testing in women aged 30\u201365 years","volume":"29","author":"Silver","year":"2018","journal-title":"Cancer Causes Control"},{"key":"2025112418274881400_bib5","article-title":"Premarket Approval (PMA): CINtec PLUS Cytology","author":"US Food & Drug Administration"},{"key":"2025112418274881400_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/LGT.0000000000000529","article-title":"Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"Egemen","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"2025112418274881400_bib7","first-page":"321","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"2025112418274881400_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"2025112418274881400_bib9","article-title":"New WHO recommendations on screening and treatment to prevent cervical cancer among women living with HIV: Policy Brief","author":"World Health Organization"},{"key":"2025112418274881400_bib10","article-title":"Trends in Hysterectomies and Oophorectomies in Hospital Inpatient and Ambulatory Settings, 2005\u20132013","author":"Agency for Healthcare Research and Quality"},{"key":"2025112418274881400_bib11","article-title":"Cancer screening test use - United States, 2015. In Morbidity and Mortality Weekly Report","author":"Centers for Disease Control and Prevention"},{"key":"2025112418274881400_bib12","article-title":"National Vital Statistics Report - Births: Final Data for 2018","author":"Centers for Disease Control and Prevention"},{"key":"2025112418274881400_bib13","article-title":"Diagnoses of HIV Infection in the United States and Dependent Areas, 2018","author":"Centers for Disease Control and Prevention"},{"key":"2025112418274881400_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ajog.2021.03.047","article-title":"The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase","volume":"225","author":"Safaeian","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2025112418274881400_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ijc.33812","article-title":"Clinical validation of p16\/Ki-67 dual-stained cytology triage of HPV-positive women: results from the IMPACT trial","volume":"150","author":"Wright","year":"2022","journal-title":"Int J Cancer"},{"key":"2025112418274881400_bib16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1158\/1055-9965.EPI-13-0973","article-title":"A population-based evaluation of cervical screening in the United States: 2008\u20132011","volume":"23","author":"Cuzick","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025112418274881400_bib17","doi-asserted-by":"crossref","first-page":"e01239","DOI":"10.1128\/JCM.01239-18","article-title":"Clinical validation of the cobas HPV test on the cobas 6800 system for the purpose of cervical screening","volume":"57","author":"Saville","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2025112418274881400_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/LGT.0b013e3181f515a2","article-title":"Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?","volume":"15","author":"Subramaniam","year":"2011","journal-title":"J Low Genit Tract Dis"},{"key":"2025112418274881400_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2014.55.9948","article-title":"Multiple biopsies and detection of cervical cancer precursors at colposcopy","volume":"33","author":"Wentzensen","year":"2015","journal-title":"J Clin Oncol"},{"key":"2025112418274881400_bib20","doi-asserted-by":"crossref","first-page":"984528","DOI":"10.1155\/2015\/984528","article-title":"Long-term clinical outcome after treatment for high-grade cervical lesions: a retrospective monoinstitutional cohort study","volume":"2015","author":"Del Mistro","year":"2015","journal-title":"Biomed Res Int"},{"key":"2025112418274881400_bib21","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.bjc.6603653","article-title":"High-risk HPV type-specific clearance rates in cervical screening","volume":"96","author":"Bulkmans","year":"2007","journal-title":"Br J Cancer"},{"key":"2025112418274881400_bib22","doi-asserted-by":"crossref","first-page":"100202","DOI":"10.1016\/j.pvr.2020.100202","article-title":"Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial","volume":"10","author":"Ferris","year":"2020","journal-title":"Papillomavirus Res"},{"key":"2025112418274881400_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CVI.00591-14","article-title":"Efficacy of human papillomavirus 16 and 18 (HPV-16\/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial","volume":"22","author":"Apter","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"2025112418274881400_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1158\/1055-9965.EPI-10-0791","article-title":"Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance","volume":"20","author":"Insinga","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025112418274881400_bib25","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2025112418274881400_bib26","article-title":"August 12. Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 May. (Evidence Syntheses, No. 86s. Appendix B Table 1)","author":"Kulasingam"},{"key":"2025112418274881400_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/LGT.0000000000000604","article-title":"The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: a systematic review and meta-analysis","volume":"25","author":"Loopik","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"2025112418274881400_bib28","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/1471-0528.16081","article-title":"Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study","volume":"127","author":"Skorstengaard","year":"2020","journal-title":"BJOG"},{"key":"2025112418274881400_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"2025112418274881400_bib30","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","article-title":"Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine","volume":"96","author":"Goldie","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"2025112418274881400_bib31","article-title":"National Vital Statistics Reports - United States Life Tables, 2017","author":"Arias"},{"key":"2025112418274881400_bib32","article-title":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2018 Sub (2000\u20132016) &lt;Katrina\/Rita Population Adjustment&gt;- Linked To County Attributes - Total U.S., 1969\u20132017 Counties, National Cancer Institute, DCCPS, Surveillance Research Program"},{"key":"2025112418274881400_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1524-4733.2009.00611.x","article-title":"Cost-effectiveness of 21 alternative cervical cancer screening strategies","volume":"13","author":"Chuck","year":"2010","journal-title":"Value Health"},{"key":"2025112418274881400_bib34","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/ijc.31265","article-title":"Quality of life assumptions determine which cervical cancer screening strategies are cost-effective","volume":"142","author":"de Kok","year":"2018","journal-title":"Int J Cancer"},{"key":"2025112418274881400_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jval.2015.02.001","article-title":"Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report","volume":"18","author":"Ramsey","year":"2015","journal-title":"Value Health"},{"key":"2025112418274881400_bib36","article-title":"Consumer Price Index: Medical Services","author":"US Bureau of Labor Statistics"},{"key":"2025112418274881400_bib37","article-title":"Health Expenditures by Age and Gender","author":"Centers for Medicare & Medicaid Services"},{"key":"2025112418274881400_bib38","article-title":"Physician\/Supplier Procedure Summary","author":"Centers for Medicare & Medicaid Services"},{"key":"2025112418274881400_bib39","article-title":"Medicare Physician Fee Schedule","author":"Centers for Medicare & Medicaid Services"},{"key":"2025112418274881400_bib40","author":"Centers for Medicare & Medicaid Services","journal-title":"Clinical Laboratory Fee Schedule"},{"key":"2025112418274881400_bib41","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-19-1534","article-title":"Medical care costs associated with cancer survivorship in the United States","volume":"29","author":"Mariotto","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025112418274881400_bib42","article-title":"2020\u20132023 Value Assessment Framework","author":"Institute for Clinical and Economic Review"},{"key":"2025112418274881400_bib43","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM modeling good research practices task force working group-6","volume":"32","author":"Briggs","year":"2012","journal-title":"Med Decis Making"},{"key":"2025112418274881400_bib44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jamainternmed.2019.0299","article-title":"Estimated quality of life and economic outcomes associated with 12 cervical cancer screening strategies: a cost-effectiveness analysis","volume":"179","author":"Sawaya","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"2025112418274881400_bib45","first-page":"27","volume-title":"Cancer Facts & Figs. 2021","author":"American Cancer Society","year":"2021"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/doi\/10.1158\/1940-6207.CAPR-22-0455\/3332685\/capr-22-0455.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/doi\/10.1158\/1940-6207.CAPR-22-0455\/3341806\/capr-22-0455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/16\/7\/393\/3342922\/393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/16\/7\/393\/3342922\/393.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T23:27:59Z","timestamp":1764026879000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/16\/7\/393\/727482\/Cost-effectiveness-of-p16-Ki-67-Dual-Stained"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,5,20]]},"published-print":{"date-parts":[[2023,7,5]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-22-0455","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.c.6709342.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563663.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563666.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627480.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563675","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563663","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563669.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627483","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6709342.v3","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6709342","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563672","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627474","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627474.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563669","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627477.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563675.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563678.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627489","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627477","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563672.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563678","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563666","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627492","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627480","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627489.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627483.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6709342.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1940-6207.23627474","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627477.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563669","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627474.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27026954","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27026966","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.30701852","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563672","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627483","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.30701855","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563678.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563675.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563672.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563666.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563663","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563669.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627492","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627483.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627480.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563663.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.30701846","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627480","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.30701858","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563675","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27026960","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627489.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27026957","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27026969.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27026969","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27026966.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27026957.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627477","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27026960.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27026963.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27026954.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27026963","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.30701849","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563666","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23563678","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.30701861","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.23627489","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]}}}